In Ethiopia, HIV disclosure is low

In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.

In the December 17 issue of AIDS Care, Ayalu Reda, a sociology graduate student, and colleagues from Jimma University in Ethiopia found that among a sample of 1,540 patients receiving antiretroviral treatment in eastern Ethiopia, a majority (66 percent) disclosed their -positive status to their spouse, while fewer disclosed to (17 percent) and other relatives (16.8 percent). A small number of patients (11.6 percent) did not disclose their status at all. None of the patients had disclosed to all of their family members. Unmarried and illiterate patients had higher levels of nondisclosure.

Reda said he was prompted to conduct the study after working in Ethiopian hospitals and seeing many patients refuse to use local medical centers, opting to be treated farther from home. "We suspected that this may be related to the fact that patients did not disclose their infection status to family members and did not want to risk being seen taking medications in nearby centers," Reda said.

This study's low disclosure rates confirmed his suspicions, highlighting a lack of awareness about the virus and a pervasive stigma surrounding those who are infected. "This will create significant obstacles to the life-long treatment process and the prevention of the spread of the virus. It may also increase . Concerted counseling efforts need to be instituted to create a supportive environment whereby could successfully disclose their infection without fear of discrimination," Reda said.

In addition to Reda, other authors on the paper were Sibhatu Biadgilign, Kebede Deribe and Amare Deribew from the College of Medical and Health Sciences at Jimma University, Ethiopia.

add to favorites email to friend print save as pdf

Related Stories

HIV status doesn't influence Hodgkin's lymphoma outcome

Oct 11, 2012

(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...

Canada high court lowers bar for HIV disclosure

Oct 05, 2012

Canada's Supreme Court on Friday decriminalized the non-disclosure of HIV status prior to sex where no realistic possibility of transmitting the potentially deadly virus exists.

Recommended for you

Withdrawal from the evolutionary race

8 hours ago

In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients ...

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

Long acting HIV drugs to be developed

Sep 11, 2014

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

User comments